多发性骨髓瘤治疗策略及治疗新药(5)
[24] Facon T， Dimopoulos MA， Dispenzieri A， et al. Initial phase 3 results of the first (Frontline Investigation of Lenalidomide+Dexamethasone versus Standard Thalidomide) trial (MM-020/IFM 0701) in newly diagnosed multiple myeloma (NDMM) patients (Pts) ineligible for stem cell transplantation (SCT) [EB/OL]. [2014-01-22]. http：//bloodjournal.hematologylibrary.org/content/122/21/2.abstract？sid=b6b11fd9-d649-47a8-be2b-ee10a36fa7fb.[25] Hou J ......
您现在查看是摘要页，全文长 1543 字符。